Redmile Group as of March 31, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 76 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 8.8 | $204M | 18M | 11.09 | |
| Krystal Biotech (KRYS) | 6.6 | $153M | 1.9M | 80.06 | |
| Iveric Bio | 4.4 | $102M | 4.2M | 24.33 | |
| Deciphera Pharmaceuticals | 3.7 | $86M | 5.6M | 15.45 | |
| Akero Therapeutics (AKRO) | 3.4 | $78M | 2.0M | 38.26 | |
| Pliant Therapeutics (PLRX) | 3.4 | $78M | 2.9M | 26.60 | |
| Fate Therapeutics (FATE) | 3.2 | $74M | 13M | 5.70 | |
| Kymera Therapeutics (KYMR) | 3.1 | $71M | 2.4M | 29.63 | |
| Celldex Therapeutics Com New (CLDX) | 2.9 | $68M | 1.9M | 35.98 | |
| Replimune Group (REPL) | 2.9 | $67M | 3.8M | 17.66 | |
| Zymeworks Del (ZYME) | 2.4 | $55M | 6.1M | 9.04 | |
| Penumbra (PEN) | 2.3 | $52M | 188k | 278.69 | |
| Livanova SHS (LIVN) | 2.2 | $52M | 1.2M | 43.58 | |
| Beam Therapeutics (BEAM) | 2.1 | $49M | 1.6M | 30.62 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.1 | $49M | 335k | 146.33 | |
| Argenx Se Sponsored Adr (ARGX) | 2.1 | $49M | 131k | 372.58 | |
| Xenon Pharmaceuticals (XENE) | 2.1 | $48M | 1.3M | 35.79 | |
| Igm Biosciences (IGMS) | 2.0 | $46M | 3.3M | 13.74 | |
| Oak Street Health | 1.8 | $41M | 1.1M | 38.68 | |
| Catalent | 1.7 | $40M | 610k | 65.71 | |
| Dex (DXCM) | 1.7 | $39M | 336k | 116.18 | |
| Stryker Corporation (SYK) | 1.7 | $39M | 137k | 285.47 | |
| Stoke Therapeutics (STOK) | 1.5 | $35M | 4.1M | 8.33 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $33M | 335k | 97.24 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $32M | 232k | 137.83 | |
| Bristol Myers Squibb (BMY) | 1.4 | $31M | 449k | 69.31 | |
| Regenxbio Inc equity us cm (RGNX) | 1.3 | $31M | 1.6M | 18.91 | |
| ImmunoGen | 1.3 | $31M | 8.0M | 3.84 | |
| Anthem (ELV) | 1.3 | $31M | 66k | 459.81 | |
| Ventyx Biosciences (VTYX) | 1.2 | $27M | 816k | 33.50 | |
| Entrada Therapeutics (TRDA) | 1.2 | $27M | 1.8M | 14.50 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.1 | $27M | 14M | 1.95 | |
| Humana (HUM) | 1.1 | $25M | 52k | 485.46 | |
| Augmedix (AUGX) | 1.1 | $25M | 14M | 1.74 | |
| Scholar Rock Hldg Corp (SRRK) | 1.1 | $25M | 3.1M | 8.00 | |
| Repare Therapeutics Ord (RPTX) | 1.1 | $25M | 2.5M | 9.84 | |
| Prime Medicine (PRME) | 1.1 | $25M | 2.0M | 12.30 | |
| Nurix Therapeutics (NRIX) | 1.1 | $24M | 2.7M | 8.88 | |
| Stevanato Group S P A Ord Shs (STVN) | 1.0 | $23M | 902k | 25.90 | |
| Charles River Laboratories (CRL) | 1.0 | $23M | 115k | 201.82 | |
| Immunovant (IMVT) | 0.9 | $20M | 1.3M | 15.51 | |
| Gritstone Oncology Ord (GRTSQ) | 0.8 | $19M | 6.9M | 2.78 | |
| Centene Corporation (CNC) | 0.8 | $18M | 277k | 63.21 | |
| Shattuck Labs (STTK) | 0.7 | $17M | 5.6M | 2.94 | |
| Atara Biotherapeutics | 0.7 | $16M | 5.6M | 2.90 | |
| Verve Therapeutics (VERV) | 0.7 | $16M | 1.1M | 14.42 | |
| Iqvia Holdings (IQV) | 0.6 | $14M | 72k | 198.89 | |
| Absci Corp (ABSI) | 0.6 | $14M | 8.0M | 1.75 | |
| 89bio (ETNB) | 0.6 | $14M | 900k | 15.23 | |
| Annexon (ANNX) | 0.6 | $14M | 3.5M | 3.85 | |
| Rapt Therapeutics | 0.5 | $13M | 688k | 18.35 | |
| Allakos | 0.4 | $10M | 2.3M | 4.45 | |
| Medavail Holdings Ord | 0.4 | $9.9M | 35M | 0.29 | |
| Boston Scientific Corporation (BSX) | 0.4 | $8.6M | 172k | 50.03 | |
| Illumina (ILMN) | 0.3 | $7.8M | 34k | 232.55 | |
| Allovir (ALVR) | 0.3 | $7.5M | 1.9M | 3.94 | |
| Science 37 Holdings | 0.2 | $5.6M | 20M | 0.28 | |
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.2 | $5.3M | 721k | 7.37 | |
| Nuvation Bio Com Cl A (NUVB) | 0.2 | $5.0M | 3.0M | 1.66 | |
| Somalogic Class A Com | 0.2 | $4.8M | 1.9M | 2.55 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.1 | $3.4M | 2.1M | 1.66 | |
| Invitae (NVTAQ) | 0.1 | $3.1M | 2.3M | 1.35 | |
| Stereotaxis Com New (STXS) | 0.1 | $3.0M | 1.5M | 2.04 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $2.7M | 587k | 4.52 | |
| Cabaletta Bio (CABA) | 0.1 | $2.3M | 274k | 8.27 | |
| Hookipa Pharma Inc equity | 0.1 | $1.9M | 2.6M | 0.74 | |
| Adagio Therapeutics (IVVD) | 0.1 | $1.7M | 1.4M | 1.20 | |
| Xeris Pharmaceuticals (XERS) | 0.1 | $1.7M | 1.0M | 1.63 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.5M | 1.6M | 0.96 | |
| Neoleukin Therapeutics | 0.1 | $1.3M | 1.8M | 0.70 | |
| Alpha Teknova (TKNO) | 0.0 | $1.1M | 373k | 2.96 | |
| Sonendo (SONX) | 0.0 | $996k | 498k | 2.00 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $988k | 658k | 1.50 | |
| Cytosorbents Corp Com New (CTSO) | 0.0 | $612k | 182k | 3.37 | |
| Atreca Cl A Com (BCEL) | 0.0 | $505k | 443k | 1.14 | |
| Oncology Institu (TOI) | 0.0 | $216k | 318k | 0.68 |